An institutional holder
Filed with the SEC on · accession 0001856079-26-000003
BRNS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Sep 11, 2026. An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership position in Barinthus Biotherapeutics plc (BRNS).
An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership position in Barinthus Biotherapeutics plc (BRNS). The filing does not disclose a change in control intent or any activist plans.
✦ Ask GOAX AI about this filing — what it means for BRNS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BRNS?
Click hereBRNS filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership position in Barinthus Biotherapeutics plc (BRNS). The filing does not disclose a change in control intent or any activist plans.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Get alerts when BRNS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days